REFERENCE
De Backer M, Lambert J, Degreef H, Lesaffre E.Belgian drug utilization study of pimecrolimus cream 1% in routine practice in atopic dermatitis. Journal of the American Academy of Dermatology 56 (Suppl. 2): 70, No. 2, Feb 2007
Rights and permissions
About this article
Cite this article
Corticosteroid-sparing, QOL effect of pimecrolimus 1%. Pharmacoecon. Outcomes News 522, 9 (2007). https://doi.org/10.2165/00151234-200705220-00025
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705220-00025